Vascular imaging market will near $6 billion by 2022

By Romily Broad
New research suggests that the global market for vascular imaging technlogies will accelerate 6.5% per year over the next five years, up to USD$5.95bill...

New research suggests that the global market for vascular imaging technlogies will accelerate 6.5% per year over the next five years, up to USD$5.95 billion by 2022.

The research from MarketsAndMarkets identifies the primary drivers as improving technlogies, aging populations, and the increasing prevelance of cardiovascular diseases (CVDs). It says North America will represent the largest market share geographically, featuring as it does both an aging population susceptible to high rates of CVD and the greatest dispursment of investment in new technlogies.

Of the technologies driving most growth, magnetic resonance imaging will dominate the market in 2017, continuing to be the preferred choice due to its non-invasiveness and high efficacy. 

Coronary angiography will dominate the cardiovascular procedure segment of the market, primarily driven by the ever increasing geriatric population of the world.

The projection sees a overall value uplift of over 25% on a market worth $4.35 billion today.

Share

Featured Articles

Grifols & Orange Business Launch Egypt Plasma Project

Grifols & Orange Business Complete landmark phase of Data Centre for Plasma Derivatives Facility, designed to boost healthcare in Egypt

Healthcare business roundup: Eli Lilly, Novo Nordisk, Aspen

Eli Lilly's experimental cardiovascular drug ‘promising’; Aspen Pharmacare to manufacture mpox vaccines; Novo Nordisk says Ozempic shortage ‘worsening’

Global Health Funding 'Facing Post-Pandemic Challenges'

IHME report highlights shifting priorities and economic pressures affecting global health financing, despite increase in funding since pre-COVID levels

The Merck Group: Pharma's History & Innovation in India

Medical Devices & Pharma

How CVS Health is Rising to the Omnichannel Challenge

Procurement & Supply Chain

Kinaxis: Pharma Seeing Euro-wide Supply Chain Challenges

Procurement & Supply Chain